The continuous monitoring of the pharmaceutical cold chain is needed to meet regulatory requirements and to guarantee the quality of APIs, intermediates and finished medicinal and life science products, to ensure patient safety. Berlinger, the Swiss headquartered monitoring provider, has its finger on the pulse of development and innovation. Due to Berlinger`s longstanding experience in temperature monitoring of pharmaceutical goods, Berlinger is well aware of the challenges that companies face to maintain the cold chain. The increasing complexity in the manufacturing and distribution of pharmaceutical products demands for end-to-end monitoring.
Register for this webinar to learn how automated condition monitoring will look like in future, and how Berlinger will solve the current pain points with their new SmartSystem solution. Berlinger will present the drivers for optimizing trade lane analytics and discuss technologies to support E2E monitoring.
Thomas Bechter, CEO, Berlinger & Co. AG
Thomas is the CEO of Berlinger & Co. AG, a leading supplier of integrated soft- and hardware temperature monitoring solutions for pharma and med-tech industries. Thomas has over 20 years’ experience in international senior management position for leading brands in various industries (Automotive, Consumer Electronic, Wholesale) with a focus on business re-modelling and transformation. Thomas holds a master’s degree in business administration from University of Bradford.Message Presenter
Marina Beer, Segment Manager Pharma & Life Science, Berlinger & Co. AG
Marina is the Segment Manager Pharma & Life Science at Berlinger & Co. AG. She has extensive experience in the field of pharmaceutical cold chain, including conditioning monitoring, temperature-controlled packaging & logistics. Marina has a proven track record in implementing hardware, software and services solutions for pharmaceutical companies successfully on a global scale, with a focus on requirements and process definition, qualification as well as operational & economic realization. In her role at Berlinger, Marina is responsible for identifying market and customer requirements, and translating them into holistic solution developments for Berlinger`s customers in cooperation with R&D.Message Presenter
Bernd Heisterkamp, Head of Research & Development, Berlinger & Co. AG
Bernd is the Head of Research and Development at Berlinger & Co. He has over 20 years’ experience as Digital Leader, Head of Engineering and international Project Manager. Bernd has in depth know-how in the development of connected devices with multi-disciplinary teams. Beside his technical knowledge, Bernd can profit from his extensive experience in business model innovation and digitalization in the industrial sector. At Berlinger, he motivates his teams to push innovation and leads Berlinger’s SmartSystem Platform development.Message Presenter
Who Should Attend?
Professionals from pharmaceutical companies who are interested in digitalization of E2E condition monitoring. Relevant job titles include Manager/Directors involved in:
- Quality Management
- Supply Chain Management/Transport/Logistics
What You Will Learn
- How event-based transparency ensures seamless quality assurances
- Drivers to optimize trade lane analytics
- How Berlinger will solve pain points related to condition monitoring with the new SmartSystem solution
Berlinger & Co. AG
The Swiss company Berlinger & Co. AG develops, produces and distributes innovative temperature monitoring solutions for pharmaceutical and medical technology products with the aim to further improve efficiency and increase patient safety.
Innovation and quality are key for us. We invest a considerable part in R&D as we are fully committed to long term customer success. We are proudly partnering with leading pharmaceutical companies and key healthcare organizations, such as WHO or UNICEF, in over 170 countries.